Abstract

The drug delivery system enables the release of the active pharmaceutical ingredient to achieve a desired therapeutic response. Conventional drug delivery systems (tablets, capsules, syrups, ointments, etc.) suffer from poor bioavailability and fluctuations in plasma drug level and are unable to achieve sustained release. Without an efficient delivery mechanism, the whole therapeutic process can be rendered useless. Moreover, the drug has to be delivered at a specified controlled rate and at the target site as precisely as possible to achieve maximum efficacy and safety. Controlled drug delivery systems are developed to combat the problems associated with conventional drug delivery. There has been a tremendous evolution in controlled drug delivery systems from the past two decades ranging from macro scale and nano scale to intelligent targeted delivery. The initial part of this review provides a basic understanding of drug delivery systems with an emphasis on the pharmacokinetics of the drug. It also discusses the conventional drug delivery systems and their limitations. Further, controlled drug delivery systems are discussed in detail with the design considerations, classifications and drawings. In addition, nano-drug delivery, targeted and smart drug delivery using stimuli-responsive and intelligent biomaterials is discussed with recent key findings. The paper concludes with the challenges faced and future directions in controlled drug delivery.

Highlights

  • IntroductionA drug (API) is a substance (recognized in official pharmacopoeia) intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease as per the FDA

  • A drug (API) is a substance intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease as per the FDA.Drug delivery is a technique of delivering medication to a patient in such a manner that increases the drug concentration in some parts of the body as compared to others [1]

  • It is the fraction of drug that is lost during absorption, and cytochrome P450 (CYP450) enzymes of the liver are accountable for the metabolism or biotransformation of about 70–80% of the drugs in clinical use [30]

Read more

Summary

Introduction

A drug (API) is a substance (recognized in official pharmacopoeia) intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease as per the FDA. Drug delivery is a technique of delivering medication to a patient in such a manner that increases the drug concentration in some parts of the body as compared to others [1]. The ultimate goal of any delivery system is to extend, confine and target the drug in the diseased tissue with a protected interaction. Every Dosage form is a combination of drug/active pharmaceutical ingredients (APIs) and the non-drug component called excipients/additives (Figure 1). APIs are the actual chemical components used to treat diseases [2]

Need for a Dosage Form
Excipients
Different Routes of Drug Administration
Classification of Solid Dosage Forms
Tablets
Bulk Solid Dosage Forms
Semisolid Dosage Forms
Ointments
Creams
Pastes
Transdermal Patches
Suppositories
Liquid Dosage Forms
Pharmacokinetics of Drug Delivery Systems
Absorption
Distribution
Metabolism
Excretion
Bioavailability
Drug Release Kinetics Basic Concepts
Controlled Drug Delivery Systems
Design Considerations of Controlled Release Drug Delivery Systems
Classification of Controlled Release Drug Delivery Systems
Dissolution Controlled Drug Delivery Systems
Diffusion-Controlled Drug Delivery Systems
Water Penetration-Controlled Drug Delivery Systems
Chemically Controlled Drug Delivery Systems
Controlled Release Dosage Form Design
Concept of Biomaterials in Controlled Drug Delivery
Nanocarriers in Controlled and Targeted Drug Delivery
Need for Targeted Drug Delivery
Active and Passive Targeting
Liposomes
Dendrimers
Exosomes
Nanoparticles
Nanosphere or Nanocapsule
Solid-Lipid Nanoparticles
Nanofibers
Polymersomes
Self-Assembled Polymeric Micelles
9.3.10. Carbon Nanotubes
9.3.11. Nanoemulsions
9.3.12. Hydrogels
10. Stimuli-Responsive Drug Delivery Systems Using Smart Biomaterials
10.1. Chemical Stimuli-Responsive Biomaterials
10.1.2. Redox Responsive
10.1.3. Enzyme Responsive
10.2.1. Light Responsive
10.2.2. Thermo-Responsive
10.2.3. Electric Responsive
10.2.4. Magnetic Responsive
10.2.5. Ultrasound Responsive
11.1. Nanomedicine Challenges and Improvements
11.2. Microfluidics in Controlled Drug Delivery
11.4. Intelligent Biomaterials
11.5. CRISPR CAS9 Based Systems
11.6. Quantum Sensing Drug Delivery
11.7. Three-Dimensional Printing in Drug Delivery
Findings
12. Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call